0001209191-15-008075.txt : 20150130
0001209191-15-008075.hdr.sgml : 20150130
20150130212801
ACCESSION NUMBER: 0001209191-15-008075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150128
FILED AS OF DATE: 20150130
DATE AS OF CHANGE: 20150130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC
CENTRAL INDEX KEY: 0001158895
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 63 2ND AVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 781-221-2266
MAIL ADDRESS:
STREET 1: 63 2ND AVE
CITY: BURLINGTON
STATE: MA
ZIP: 01803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gebauer Peter R
CENTRAL INDEX KEY: 0001365741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33092
FILM NUMBER: 15564758
MAIL ADDRESS:
STREET 1: AM WALDFELD 17
CITY: BAD SODEN
STATE: 2M
ZIP: 65812
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-28
0
0001158895
LEMAITRE VASCULAR INC
LMAT
0001365741
Gebauer Peter R
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE
BURLINGTON
MA
01803
0
1
0
0
President, International OP
Common Stock
2015-01-28
4
M
0
4094
0.102
A
45960
D
Common Stock
2015-01-28
4
S
0
4094
7.9115
D
41866
D
Common Stock
2015-01-29
4
M
0
12825
0.102
A
54691
D
Common Stock
2015-01-29
4
S
0
12825
7.9056
D
41866
D
Stock Option (Right to Buy)
0.102
2015-01-28
4
M
0
4094
0.00
D
1997-06-02
2007-06-02
Common Stock
4094
186295
D
Stock Option (Right to Buy)
0.102
2015-01-29
4
M
0
12825
0.00
D
1997-06-02
2007-06-02
Common Stock
12825
173470
D
Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.94. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.95. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
This option is fully vested and exercisable.
This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.
/s/ Laurie Churchill, Attorney-in-fact
2015-01-30